Keynote address: variations in the natural history of HIV infection
- PMID: 7811537
- DOI: 10.1089/aid.1994.10.883
Keynote address: variations in the natural history of HIV infection
Abstract
In general, the natural history of HIV infection as revealed by prospective cohort studies such as the Multicenter AIDS Cohort Study (MACS) is consistent with our current understanding of the immunopathogenesis of HIV disease. Although the limitations of CD4+ T cell counts as a predictor of response to therapy are now recognized, enumeration of these cells remains an important predictor of outcome. Additional information regarding prognosis can be obtained using other immunological and virological information. Analysis of data from cohort studies has revealed varying patterns of CD4+ lymphocyte count decline associated with differing evidence of immune activation, specific antibody responses, CD8+ T cell responses, and level of viral burden. Of interest, some asymptomatic HIV-infected persons appear to show immune stability in the absence of therapeutic interventions. In addition, the combination of antiretroviral therapy and prophylaxis for Pneumocystis carinii pneumonia (but apparently not prophylaxis for fungal or Mycobacterium avium-intracellulare infections) has prolonged survival in patients with AIDS.
Similar articles
-
Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.Antivir Ther. 2006;11(3):343-50. Antivir Ther. 2006. PMID: 16759051 Free PMC article.
-
Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.AIDS Res Hum Retroviruses. 2001 Mar 1;17(4):329-35. doi: 10.1089/08892220150503690. AIDS Res Hum Retroviruses. 2001. PMID: 11242519
-
Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.HIV Med. 2005 Jul;6(4):278-83. doi: 10.1111/j.1468-1293.2005.00307.x. HIV Med. 2005. PMID: 16011533
-
Immunological recovery and antiretroviral therapy in HIV-1 infection.Lancet Infect Dis. 2006 May;6(5):280-7. doi: 10.1016/S1473-3099(06)70463-7. Lancet Infect Dis. 2006. PMID: 16631548 Review.
-
[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Enferm Infecc Microbiol Clin. 2011. PMID: 21388714 Spanish.
Cited by
-
An optimized sensitive method for quantitation of DNA/RNA viruses in heparinized and cryopreserved plasma.J Virol Methods. 2011 Sep;176(1-2):1-8. doi: 10.1016/j.jviromet.2011.05.012. Epub 2011 May 17. J Virol Methods. 2011. PMID: 21645549 Free PMC article.
-
Virus phenotype switching and disease progression in HIV-1 infection.Proc Biol Sci. 1999 Dec 22;266(1437):2523-30. doi: 10.1098/rspb.1999.0955. Proc Biol Sci. 1999. PMID: 10693824 Free PMC article.
-
Trends and Adaptive Optimal Set Points of CD4+ Count Clinical Covariates at Each Phase of the HIV Disease Progression.AIDS Res Treat. 2020 Mar 1;2020:1379676. doi: 10.1155/2020/1379676. eCollection 2020. AIDS Res Treat. 2020. PMID: 32190387 Free PMC article.
-
Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL.Sci Rep. 2019 Jun 28;9(1):9371. doi: 10.1038/s41598-019-45479-3. Sci Rep. 2019. PMID: 31253857 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous